Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Mild traumatic brain injury (mTBI) is associated with substantial morbidity worldwide. Emerging evidence demonstrates that both impact- and blast-related mTBI produce diffuse microstructural and functional alterations, e.g., diffuse axonal injury, astroglial and microglial activation, cerebrovascular dysfunction, and neurometabolic disturbance. Rotational acceleration in impact injury preferential...
Alzheimer's disease (AD) is a major cause of dementia, and this paper explores the unclear roles of mitochondrial dysfunction and programmed cell death in AD. Differentially expressed genes (DEGs) were identified using AD datasets GSE63061 and GSE63060 from the Gene Expression Omnibus. DEGs were intersected with mitochondria-related genes and programmed cell death-related genes to obtain DEGs (in ...
In the originally published article entitled "A Comprehensive Review on Deep Learning Techniques in Alzheimer's Disease Diagnosis", published in "Curr...
BACKGROUND: Adenomyosis diagnosis and classification relies primarily on magnetic resonance imaging or pathological examination. Liquid biopsy has bee...
Structural dynamics play critical roles for the biological activity of protein molecules. Characterizing the inherent conformational landscapes of the...
Mild cognitive impairment (MCI) is a critical transitional stage between normal aging and dementia that remains challenging to detect. Many traditiona...
BACKGROUND: Chronic illness may cause a financial burden that affects patients, their caregivers, and families. While international research, mostly f...
Alzheimer's disease, a progressive neurodegenerative disorder, presents a growing global health challenge due to its increasing prevalence and lack of...
BACKGROUND: Predicting Alzheimer's disease (AD)-related cognitive impairment (CI) among cognitively normal (CN) adults enables meaningful disease modi...
Magnetic resonance imaging (MRI) plays a pivotal role in the diagnostic work-up of dementia. In addition to excluding secondary and potentially treata...
Alzheimer's disease (AD) is a dementia disease that causes loss of cognitive functions. Also, it is a noncurable disease. However, early diagnosis and...
BackgroundVascular factors contribute to dementia in approximately 20 million individuals, notably in vascular contributions to cognitive impairment a...
BackgroundDementia disorders are affecting millions of people globally, characterized by memory loss, communication difficulties, and motor function d...
Acute care hospitals often fail to meet the relational needs of older adults with dementia, for whom many environmental stressors can exacerbate behav...
OBJECTIVE: Pre-mortem diagnosis of parkinsonism is often challenging due to atypical presentations, overlapping syndromes, and co-pathologies. This st...
Neurodegenerative diseases (NDs), including Alzheimer's, Parkinson's, Huntington's, amyotrophic lateral sclerosis, and multiple sclerosis, share a com...
BackgroundPredicting cognitive function across dementia stages remains challenging. Plasma biomarkers and electroencephalogram (EEG) features may prov...
BackgroundAcetyl tributyl citrate (ATBC), an eco-friendly plasticizer, exhibits poorly characterized neurotoxic effects.ObjectiveWe integrated network...
BACKGROUND: Observational data are fundamental to medical research but present formidable challenges for causal inference. Machine learning-based caus...
Dementia, a progressively debilitating neurodegenerative disorder, poses a growing challenge to global healthcare due to its subtle early onset and la...